↓ Skip to main content

Therapeutic Targets of the TNF Superfamily

Overview of attention for book
Attention for Chapter 2: Therapeutic Interventions Targeting CD40L (CD154) and CD40: The Opportunities and Challenges
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (82nd percentile)
  • High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

patent
4 patents
wikipedia
2 Wikipedia pages

Citations

dimensions_citation
13 Dimensions

Readers on

mendeley
55 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
Therapeutic Interventions Targeting CD40L (CD154) and CD40: The Opportunities and Challenges
Chapter number 2
Book title
Therapeutic Targets of the TNF Superfamily
Published in
Advances in experimental medicine and biology, January 2017
DOI 10.1007/978-0-387-89520-8_2
Pubmed ID
Book ISBNs
978-0-387-89519-2, 978-0-387-89520-8
Authors

Che-Leung Law, Iqbal S. Grewal

Editors

Iqbal S. Grewal PhD

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 55 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Belgium 1 2%
Luxembourg 1 2%
Unknown 53 96%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 11 20%
Researcher 11 20%
Student > Bachelor 4 7%
Other 4 7%
Student > Master 4 7%
Other 6 11%
Unknown 15 27%
Readers by discipline Count As %
Agricultural and Biological Sciences 12 22%
Medicine and Dentistry 12 22%
Immunology and Microbiology 4 7%
Pharmacology, Toxicology and Pharmaceutical Science 3 5%
Biochemistry, Genetics and Molecular Biology 3 5%
Other 4 7%
Unknown 17 31%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 December 2021.
All research outputs
#3,253,363
of 22,675,759 outputs
Outputs from Advances in experimental medicine and biology
#561
of 4,904 outputs
Outputs of similar age
#71,131
of 418,773 outputs
Outputs of similar age from Advances in experimental medicine and biology
#48
of 489 outputs
Altmetric has tracked 22,675,759 research outputs across all sources so far. Compared to these this one has done well and is in the 84th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,904 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.0. This one has done well, scoring higher than 88% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 418,773 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 82% of its contemporaries.
We're also able to compare this research output to 489 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 90% of its contemporaries.